<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03969368</url>
  </required_header>
  <id_info>
    <org_study_id>BTL-099-U2</org_study_id>
    <nct_id>NCT03969368</nct_id>
  </id_info>
  <brief_title>rPMS Compared With Pelvic Floor Exercises for Treatment of Urinary Incontinence</brief_title>
  <official_title>Randomized Trial of rPMS Pelvic Floor Stimulation Device Compared With Pelvic Floor Exercises for Treatment of Urinary Incontinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BTL Industries Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>BTL Industries Ltd.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare the clinical efficacy and safety between rPMS device and pelvic floor&#xD;
      exercises for the treatment of urinary incontinence. The subjects will be enrolled and&#xD;
      assigned into two study groups - active and control group. Subjects will be required to&#xD;
      complete six (6) treatment visits and five follow-up visits - 1, 3, 6, 9 and 12 months after&#xD;
      the final treatment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Anticipated">November 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of quality of life improvement using the UDI-6 questionnaire</measure>
    <time_frame>13 months</time_frame>
    <description>Evaluation of change in UDI-6 score before and after the study treatment in both study groups. Decrease of the score will be considered as an improvement.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of incontinence episodes using Bladder diary</measure>
    <time_frame>13 months</time_frame>
    <description>Evaluation of change in incontinence episodes before and after the study treatment in both study groups.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of quality of life improvement using the ICIQ-LUTSqol questionnaire</measure>
    <time_frame>13 months</time_frame>
    <description>Evaluation of change in ICIQ-LUTSqol score before and after the study treatment in both study groups. Decrease of the score will be considered as an improvement.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of quality of life improvement using the Pad Usage Questionnaire</measure>
    <time_frame>13 months</time_frame>
    <description>Evaluation of change in Pad Usage Questionnaire before and after the study treatment in both study groups. Decrease in number of used pads will be considered as an improvement.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of pelvic floor muscle strength</measure>
    <time_frame>13 months</time_frame>
    <description>Evaluation of pelvic floor muscle strength with measurement of voluntary contraction in both study groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subject Satisfaction evaluation</measure>
    <time_frame>13 months</time_frame>
    <description>Qualitative analysis of subject's opinion using a questionnaire. Subjects will be asked to describe the change and their satisfaction after the study treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Therapy comfort evaluation</measure>
    <time_frame>1 month</time_frame>
    <description>Evaluation of therapy comfort after each treatment or training session using the questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety evaluation</measure>
    <time_frame>13 months</time_frame>
    <description>Incidence of adverse events (AE) associated with study device will be followed.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>Treatment Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment with the investigational device - rPMS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>rPMS device</intervention_name>
    <description>Pelvic floor muscle contractions will be induced by the rPMS device.</description>
    <arm_group_label>Treatment Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pelvic floor muscle training</intervention_name>
    <description>Control group will undergo a pelvic floor muscle training</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female aged 25-70 years&#xD;
&#xD;
          -  Suffers from specific types of UI - Stress Urinary Incontinence (SUI), Urge Urinary&#xD;
             Incontinence (UUI) and/or Mixed Urinary Incontinence (MUI)&#xD;
&#xD;
          -  Voluntarily signed informed consent form&#xD;
&#xD;
          -  Subjects willing and able to abstain from partaking in any treatment of urinary&#xD;
             incontinence other than the study procedure&#xD;
&#xD;
          -  Subjects currently undergoing any treatment for stress, urge and/or mixed urinary&#xD;
             incontinence, have to undergo a two-week wash-out period before start of the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Use of Botox® in the bladder or pelvic muscles in the last year&#xD;
&#xD;
          -  Use of Interstim® or similar device for the treatment of UI&#xD;
&#xD;
          -  Suffers from other types of urinary incontinence other than SUI, UUI, MUI&#xD;
&#xD;
          -  Pelvic organ prolapse grade 2 and higher&#xD;
&#xD;
          -  Pronounced lesions of the pudendus nerve during clinical neurophysiological&#xD;
             examination&#xD;
&#xD;
          -  Currently lactating&#xD;
&#xD;
          -  Cardiac pacemakers&#xD;
&#xD;
          -  Implanted defibrillators and/or neurostimulators&#xD;
&#xD;
          -  Electronic implants&#xD;
&#xD;
          -  Metal implants, including copper IUD&#xD;
&#xD;
          -  Drug pumps&#xD;
&#xD;
          -  Hemorrhagic conditions&#xD;
&#xD;
          -  Anticoagulation therapy&#xD;
&#xD;
          -  Fever&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Following recent surgical procedures when muscle contraction may disrupt the healing&#xD;
             process&#xD;
&#xD;
          -  Application over areas of the skin which lack normal sensation&#xD;
&#xD;
          -  Any disorders that the Investigator deems would interfere with study endpoints or&#xD;
             subject safety&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Boston Urogyn</name>
      <address>
        <city>Wellesley</city>
        <state>Massachusetts</state>
        <zip>02481</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Urogynecology and Reconstructive Surgery</name>
      <address>
        <city>Somerset</city>
        <state>New Jersey</state>
        <zip>08873</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Female Pelvic Health Center</name>
      <address>
        <city>Newtown</city>
        <state>Pennsylvania</state>
        <zip>18940</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Female Pelvic Medicine Institute</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23225</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>May 28, 2019</study_first_submitted>
  <study_first_submitted_qc>May 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2019</study_first_posted>
  <last_update_submitted>January 28, 2021</last_update_submitted>
  <last_update_submitted_qc>January 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

